Evaluating tirzepatide for treating obesity in adolescents
Official title: Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in Adolescents: A Randomized, Double-Blind, Placebo- Controlled Trial (SURMOUNT-ADOLESCENTS-2)
Run by Eli Lilly and Company · NCT06439277 · Data updated 2026-11-12
This study is testing if tirzepatide can help teenagers with obesity lose weight and improve their heart health while they follow a healthy eating and exercise program.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 12 Years to 17 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Eli Lilly and Company Industry-sponsored |
| Locations | 69 sites (Los Angeles, California and 68 other locations) |
| Status | Recruiting |
| Started | June 3, 2024 |
| Main results expected | October 2027 |
| Study ends | December 2030 |
| Registry record updated | September 24, 2026 |
| Trial ID | NCT06439277 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adolescents with a BMI at or above the 95th percentile for their age and sex, along with at least two weight-related comorbidities.
✕Probably not a fit
Patients who have undergone weight reduction procedures or have recently lost significant weight may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the effects of tirzepatide on body weight and cardiovascular risk factors in adolescents with obesity and related health issues. Participants will receive either tirzepatide or a placebo while following a program that includes healthy nutrition and physical activity. The study will last approximately 76 weeks and may involve up to 23 visits to monitor progress and safety. The primary focus is on determining the safety and efficacy of tirzepatide in this population.
Why it matters
Potential benefit: If successful, this treatment could significantly improve weight management and reduce health risks in adolescents with obesity.
How similar studies have gone: Other studies have shown promising results with tirzepatide in adult populations, but this specific approach in adolescents is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have body mass index (BMI) equal to or above the 95th percentile for age and sex (on age and gender-specific growth chart for diagnosis of obesity) with at least 2 of the following predefined weight-related comorbidities: hypertension, prediabetes and hypertriglyceridemia. * Have history of at least 1 self-reported unsuccessful dietary effort to lose weight. * Are capable of giving signed informed consent by a legal representative or assent by a study participant (when applicable). Exclusion Criteria: * Have undergone or plan to undergo a weight reduction procedure during the study, such as, but not limited to * gastric bypass * sleeve gastrectomy * restrictive bariatric surgery, such as Lap-Band gastric banding, or * any other procedure intended to result in weight reduction. * Have a self-reported, or by parent or legal guardian where applicable, decrease in body weight greater than 5 kg (11 lbs) within 90 days before screening irrespective of medical records * Have type 1 diabetes or history of ketoacidosis, or hyperosmolar state * Have type 2 diabetes or have a HbA1c \> 6.4% at screening * Have a history of chronic or acute pancreatitis * Have a family or personal history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
Where it's running
-
Winterberry Research Inc.
Hamilton, Canada Recruiting -
Children's Hospital Los Angeles
Los Angeles, California, United States Active not recruiting -
Sutter Valley Medical Foundation (SVMF) Pediatric Endocrinology
Sacramento, California, United States Active not recruiting -
Nemours Children's Health - Delaware
Wilmington, Delaware, United States Active not recruiting -
Medical Research Partners
Ammon, Idaho, United States Active not recruiting -
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States Active not recruiting
Show 44 more locations
-
Indiana University Health University Hospital
Indianapolis, Indiana, United States Active not recruiting -
UBMD Pediatrics
Buffalo, New York, United States Active not recruiting -
SUNY Upstate Medical University
Syracuse, New York, United States Active not recruiting -
Driscoll Children's Hospital
Corpus Christi, Texas, United States Active not recruiting -
Epic Medical Research - DeSoto
DeSoto, Texas, United States Active not recruiting -
Valley Institute of Research - Fort Worth
Fort Worth, Texas, United States Active not recruiting -
Consano Clinical Research, LLC
Shavano Park, Texas, United States Active not recruiting -
Texas Valley Clinical Research
Weslaco, Texas, United States Active not recruiting -
Alliance for Multispecialty Research, LLC
Layton, Utah, United States Completed -
Investigaciones Medicas Imoba Srl
Buenos Aires, Argentina Active not recruiting -
Centro de Investigaciones Metabólicas (CINME)
Buenos Aires, Argentina Active not recruiting -
Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada
Buenos Aires, Argentina Active not recruiting -
Fundación Respirar
Buenos Aires, Argentina Completed -
DIM Clínica Privada
Ramos Mejía, Argentina Active not recruiting -
Centro de Investigaciones Médicas Tucuman
SAN M. de Tucuman, Argentina Active not recruiting -
Nightingale Research
Adelaide, Australia Completed -
Cornerstone Dermatology
Coorparoo, Australia Active not recruiting -
Perth Children's Hospital
Perth, Australia Completed -
University of Sydney - Charles Perkins Centre
Sydney, Australia Active not recruiting -
Premier Clinical Trial Network
Hamilton, Canada Not yet recruiting -
Bluewater Clinical Research Group Inc.
Sarnia, Canada Completed -
Centre Hospitalier Universitaire d'Angers
Angers, France Active not recruiting -
Hospices Civils de Lyon - Hopital Louis Pradel
Bron, France Active not recruiting -
Hôpital Jeanne de Flandre
Lille, France Active not recruiting -
Assistance Publique Hôpitaux de Marseille - Hôpital de la Timone
Marseille, France Active not recruiting -
Hôpital Armand Trousseau
Paris, France Active not recruiting -
Assistance Publique - Hopitaux de Paris (AP-HP) - Hopital Robert Debre - Centre Hospitalo Universitaire (C -T
Paris, France Active not recruiting -
CHU de Toulouse - Hôpital des Enfants
Toulouse, France Completed -
Universitaetsklinikum Koeln
Cologne, Germany Active not recruiting -
Universitätsklinikum Leipzig
Leipzig, Germany Active not recruiting -
Universitaetsklinikum Ulm
Ulm, Germany Active not recruiting -
Emek Medical Center
Afula, Israel Completed -
Soroka Medical Center
Beersheba, Israel Active not recruiting -
Rambam Health Care Campus
Haifa, Israel Active not recruiting -
Carmel Hospital
Haifa, Israel Active not recruiting -
Shaare Zedek Medical Center
Jerusalem, Israel Completed -
Meir Medical Center
Kfar Saba, Israel Active not recruiting -
Schneider Children's Medical Center
Petah Tikva, Israel Active not recruiting -
Sheba Medical Center
Ramat Gan, Israel Active not recruiting -
Centro de Atención e Investigación Clínica
Aguascalientes, Mexico Active not recruiting -
Centro de Investigacion Medica de Occidente, S.C.
Guadalajara, Mexico Active not recruiting -
Christus - Latam Hub Center of Excellence and Innovation S.C.
Monterrey, Mexico Active not recruiting -
Clínica García Flores SC
Monterrey, Mexico Active not recruiting -
Consultorio Médico de Endocrinología y Pediatría
Puebla City, Mexico Active not recruiting
+19 more sites. See ClinicalTrials.gov for the full list.
Study contacts
- Study coordinator: Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
- Email: LillyTrials@Lilly.com
- Phone: 1-317-615-4559
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High-intensity interval exercise to support brain activity and weight maintenance
This trial will test whether a 12-week high-intensity interval training (HIIT) program changes brain activity and helps with weight maintenance in adults 18–70, including people who regained weight after bariatric surgery.
-
Comparing two methods for weight loss after gastric bypass
This study is testing two different ways to help people who have gained weight after gastric bypass surgery lose weight again, to see which method works better and is safer.
-
Obesity prevention program for high-risk infants
This study is testing a parenting program to help prevent obesity in infants from low-income or minority communities during regular doctor visits.
-
Understanding how sleep affects metabolism and weight gain
This study is testing how not getting enough sleep and the timing of sleep can affect metabolism and weight gain in people.
-
Effects of exercise on fat tissue in obese individuals
This study tests how exercise affects fat tissue in people with obesity to see if it can help improve their metabolism and manage weight better.
-
Ocular Changes in People Using Tirzepatide or Semaglutide
This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.